Omnicell

OMCL US Health Care Health Care Technology
S&P 600
$32.79
+1.67%
Delayed · cached 15 min
Fair Value Analysis →

Price Chart

Price50-day avg200-day avg

How to read this: the line is the closing price over time. The two dashed lines are moving averages — the average price over the last 50 and 200 trading days — which smooth out daily noise to show the broader trend. Price above its moving averages reflects recent strength; below reflects recent weakness. Use the buttons to change the time range. Prices are end-of-day, not live.

Strengths

No standout strengths flagged by the automated checks.

!Watch-points

  • Return on equity is on the lower side at 0.2%.
  • Return on capital employed is on the lower side at 0.3%.
  • Net profit margin is slim at 0.2%.

These points are generated automatically from the company’s reported figures to highlight what stands out. They are descriptive observations for educational purposes only — not advice or a recommendation to buy, sell, or hold.

Forensic Checks

Altman Z-ScoreGrey zone
2.36

This middle range was less conclusive in Altman’s study — neither clearly safe nor clearly distressed.

Piotroski F-ScoreModerate
6 / 7

The F-Score adds one point for each of several year-on-year signs of improving profitability, lower leverage and better efficiency. Higher is generally stronger.

Based on 7 of the 9 signals — the rest need data not available for this stock.

These are well-known academic screening models, shown for educational context only. They describe historical financial patterns and are not predictions, advice, or a recommendation to buy, sell, or hold.

Key Ratios

Market Cap$1.49B
Current Price$ 32.79
High / Low$ 55.00 / 29.06
Stock P/E39.035717
Book Value$ 27.90
Dividend Yield0%
ROCE0.34%
ROE0.16%
Current Ratio1.43
P/B Ratio1.1579617
EPS$ 0.04
PAT Margin0.17%
Cash PAT$80.85M
Educational data only. Not a recommendation to buy, sell or hold any security.